Lidocaine-prilocaine (EMLA(®) ) cream as analgesia in hysteroscopy practice: a prospective, randomized, non-blinded, controlled study.

Baldomero Arnau, Esther Jovell, Stephanie Redón, Marta Canals, Vanessa Mir, Elena Jiménez

Obstetrics and Gynecology Service, Health Consortium of Terrassa, Barcelona, Spain. barnau@cst.cat

Acta obstetricia et gynecologica Scandinavica 2013 Aug

filter terms:

We investigated the efficacy of 5% lidocaine 25 mg-prilocaine 25 mg/g cream (EMLA(®) ) applied to the uterine cervix for reducing pain during diagnostic or operative hysteroscopy, using a visual analogue scale (VAS) for pain in a prospective randomized, non-blinded, controlled study in 92 successive patients. Patients were randomized to either 3 mL of EMLA cream or 3 mL of ultrasound gel (placebo), placed endocervically and exocervically, 10 min before hysteroscopy. Intensity of pain was evaluated immediately after the procedure using a 10-cm VAS. No differences were found between the two groups (p = 0.07). The number of women who wished to stop the procedure was significantly lower in the EMLA group compared with the control group (p = 0.013). We concluded that topical instillation of EMLA does not decrease pain during hysteroscopy, but does reduce a desire to abandon the procedure. © 2013 Nordic Federation of Societies of Obstetrics and Gynecology.

Citation

Baldomero Arnau, Esther Jovell, Stephanie Redón, Marta Canals, Vanessa Mir, Elena Jiménez. Lidocaine-prilocaine (EMLA(®) ) cream as analgesia in hysteroscopy practice: a prospective, randomized, non-blinded, controlled study. Acta obstetricia et gynecologica Scandinavica. 2013 Aug;92(8):978-81